CelLBxHealth plc
OTC: ANPCY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Peter Collins
- Employees
- 119
- Headquarters
- Guildford, United Kingdom
- IPO year
- 2015
- Market cap
- $22.0M
- Website
- https://cellbxhealth.com
Loading ANPCY…
Loading profile data…Frequently asked questions about ANPCY
What does CelLBxHealth plc (ANPCY) do?
Headquartered in Guildford, United Kingdom, and established in 1994, CelLBxHealth plc (formerly known as ANGLE plc until October 2025) is a medical diagnostics company dedicated to advancing cancer detection. The firm's reach extends globally, with operations in the UK, Europe, and North America. CelLBxHealth's product portfolio features innovat...
Where does ANPCY trade?
CelLBxHealth plc (ANPCY) trades on the Other OTC.
What sector is ANPCY in?
CelLBxHealth plc (ANPCY) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of CelLBxHealth plc?
Peter Collins is the chief executive officer of CelLBxHealth plc (ANPCY).
Where is CelLBxHealth plc headquartered?
CelLBxHealth plc is headquartered in United Kingdom.
Does ANPCY pay a dividend?
CelLBxHealth plc (ANPCY) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ANPCY go public?
CelLBxHealth plc (ANPCY) completed its initial public offering in 2015.
Is ANPCY an ADR?
Yes — ANPCY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. CelLBxHealth plc reporting and dividends follow the underlying issuer.